Methods for preparation of recombinant cytokine proteins V. mutant analogues of human interferon-gamma with higher stability and activity

Protein Expr Purif. 2002 Mar;24(2):173-80. doi: 10.1006/prep.2001.1565.

Abstract

Mutant analogues of recombinant human immune interferon (IFN-gamma) with higher stability and biological activity were prepared. Depending on the analogue, protein structure modification might involve introduction of an intramonomer disulfide bond (through replacements of Glu7Cys and Ser69Cys), C-terminal shortening by 10 amino acid residues, as well as Gln133Leu substitution in truncated variant. Isolation, purification, and renaturation of the IFN-gamma analogues expressed in Escherichia coli as inclusion bodies were performed according to the scheme developed earlier for wild-type protein. The main idea of this scheme is to remove cellular impurities before recombinant protein renaturation. Folding kinetics of IFN-gamma was studied by reversed-phase HPLC. IFN-gamma and mutant proteins were characterized by their thermal stability and biological activity. Introduction of the intramolecular disulfide bond together with C-terminal shortening and replacement of C-terminal residue was shown to result in increasing the thermal stability by 19 degrees C and four times enhancement of biological activity compared with intact IFN-gamma molecule.

MeSH terms

  • Antiviral Agents / chemistry
  • Antiviral Agents / isolation & purification
  • Drug Stability
  • Escherichia coli
  • Humans
  • Interferon-gamma / chemistry
  • Interferon-gamma / genetics*
  • Interferon-gamma / isolation & purification
  • Mutation
  • Protein Engineering / methods*
  • Protein Folding
  • Protein Renaturation
  • Recombinant Proteins
  • Temperature

Substances

  • Antiviral Agents
  • Recombinant Proteins
  • Interferon-gamma